Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism TNF inhibitors(Tumor necrosis factor inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors), TNFR inhibitors(Tumor necrosis factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Discovery | - | 02 Apr 2024 | |
| Endocrinology and Metabolic Disease | Discovery | - | 02 Apr 2024 | |
| Glomerulonephritis | Discovery | - | 02 Apr 2024 | |
| Hemic and Lymphatic Diseases | Discovery | - | 02 Apr 2024 | |
| Hepatitis C | Discovery | - | 02 Apr 2024 | |
| Immune System Diseases | Discovery | - | 02 Apr 2024 | |
| Neoplasms | Discovery | - | 02 Apr 2024 | |
| Other Diseases | Discovery | - | 02 Apr 2024 | |
| Respiratory Diseases | Discovery | - | 02 Apr 2024 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 02 Apr 2024 |





